12.11
+1.76%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Corteva annual report
Filed with the US Securities and Exchange Commission
The latest annual report covers the year to 31 Dec 2025, filed on 12 Feb 2026.
Read the 10-K on SEC.gov ↗Five-year highlights
In USD.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $17.40bn | $16.91bn | $17.23bn | $17.45bn | $15.65bn |
| Operating income | $2.62bn | $2.10bn | $941.0m | $1.93bn | $1.35bn |
| Net income | $1.09bn | $907.0m | $735.0m | $1.15bn | $1.76bn |
| Free cash flow | $2.81bn | $1.55bn | $1.17bn | $267.0m | $2.15bn |
| Total assets | $42.84bn | $40.83bn | $43.00bn | $42.62bn | $42.34bn |
| Shareholders' equity | $24.14bn | $23.79bn | $25.04bn | $25.30bn | $25.38bn |
Revenue by business
Year to 31 Dec 2025
- Corn [Member] $7.00bn · 40.2%
- Herbicides [Member] $3.73bn · 21.4%
- Soybean [Member] $1.88bn · 10.8%
- Insecticides [Member] $1.67bn · 9.6%
- Fungicides [Member] $1.14bn · 6.6%
- Other oilseeds [Member] $644.0m · 3.7%
- Biologicals $519.0m · 3.0%
- Other [Member] $445.0m · 2.6%
Revenue by region
Year to 31 Dec 2025
- UNITED STATES $8.27bn · 47.5%
- Latin America $3.93bn · 22.6%
- EMEA $3.11bn · 17.9%
- BRAZIL $2.90bn · 16.7%
- North America [Member] $2.75bn · 15.8%
- Asia Pacific $1.34bn · 7.7%
- CANADA $755.0m · 4.3%
From the 2025 annual report
As filed, for the year to . A later report may be linked above: this is the newest our data supplier has processed.
- Auditor
- PricewaterhouseCoopers LLP
- Auditor location
- Philadelphia, Pennsylvania
Income statement USD ($) $ in Millions
| Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023 | |||
|---|---|---|---|---|---|
| Net Sales | — | 17,401 | 16,908 | 17,226 | |
| Cost of Goods Sold | — | 9,172 | 9,529 | 9,920 | |
| Research and Development Expense | — | 1,474 | 1,402 | 1,337 | |
| Selling, General and Administrative Expense | — | 3,492 | 3,196 | 3,176 | |
| Amortization of Intangibles | — | 644 | 685 | 683 | |
| Restructuring and asset related charges - net | [1] | 146 | 288 | 336 | |
| Business Separation Costs | — | 35 | 0 | 0 | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | — | Other income (expense) - net | Other income (expense) - net | Other income (expense) - net | |
| Other income (expense) - net | — | -570 | -300 | -448 | |
| Interest Expense | — | 180 | 233 | 233 | |
| Income (loss) from continuing operations before income taxes | — | 1,688 | 1,275 | 1,093 | |
| Provision for (benefit from) income taxes on continuing operations | — | 484 | 412 | 152 | |
| Income (loss) from continuing operations after income taxes | — | 1,204 | 863 | 941 | |
| Income (loss) from discontinued operations after income taxes | — | -99 | 56 | -194 | |
| Net income (loss) | — | 1,105 | 919 | 747 | |
| Net income (loss) attributable to noncontrolling interests | — | 11 | 12 | 12 | |
| Net Income (Loss) attributable to Company | — | 1,094 | 907 | 735 | |
| Basic earnings (loss) per share of common stock from continuing operations | — | 1.75 | 1.23 | 1.31 | |
| Basic earnings (loss) per share of common stock from discontinued operations | — | -0.15 | 0.08 | -0.27 | |
| Basic earnings (loss) per share of common stock | — | 1.6 | 1.31 | 1.04 | |
| Diluted earnings (loss) per share of common stock from continuing operations | — | 1.75 | 1.22 | 1.3 | |
| Diluted earnings (loss) per share of common stock from discontinued operations | — | -0.15 | 0.08 | -0.27 | |
| Diluted earnings (loss) per share of common stock | — | 1.6 | 1.3 | 1.03 | |
| Net Sales | — | 17,401 | 16,908 | 17,226 | |
| Cost of Goods Sold | — | 9,172 | 9,529 | 9,920 | |
| Research and Development Expense | — | 1,474 | 1,402 | 1,337 | |
| Selling, General and Administrative Expense | — | 3,492 | 3,196 | 3,176 | |
| Amortization of Intangibles | — | 644 | 685 | 683 | |
| Restructuring and asset related charges - net | — | 146 | 288 | 336 | |
| Business Separation Costs | — | 35 | 0 | 0 | |
| Other income (expense) - net | — | -570 | -261 | -448 | |
| Interest Expense | — | 180 | 233 | 253 | |
| Income (loss) from continuing operations before income taxes | — | 1,688 | 1,314 | 1,073 | |
| Provision for (benefit from) income taxes on continuing operations | — | 484 | 421 | 147 | |
| Income (loss) from continuing operations after income taxes | — | 1,204 | 893 | 926 | |
| Income (loss) from discontinued operations after income taxes | — | -99 | 56 | -194 | |
| Net income (loss) | — | 1,105 | 949 | 732 | |
| Net income (loss) attributable to noncontrolling interests | — | — | 2 | 2 | |
| Net Income (Loss) attributable to Company | — | 1,104 | 947 | 730 | |
| [1] Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information. | — | — | — | [1] | Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information. |
| [1] | Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information. |
Balance sheet USD ($) shares in Thousands, $ in Millions
| 4,521 | 3,106 | |
|---|---|---|
| Marketable Securities | 9 | 63 |
| Accounts and notes receivable - net | 6,371 | 5,676 |
| Inventories | 5,667 | 5,432 |
| Other current assets | 767 | 820 |
| Total current assets | 17,335 | 15,097 |
| Investments in nonconsolidated affiliates | 160 | 134 |
| Property, Plant and Equipment | 9,551 | 9,074 |
| Less: Accumulated Depreciation | 5,331 | 4,975 |
| Net Property, Plant and Equipment | 4,220 | 4,099 |
| Goodwill | 10,465 | 10,408 |
| Other intangible assets | 8,301 | 8,876 |
| Deferred Income Taxes | 320 | 401 |
| Other Assets | 2,044 | 1,810 |
| Total Assets | 42,845 | 40,825 |
| Short-term borrowings and finance lease obligations | 894 | 750 |
| Accounts Payable | 4,398 | 4,039 |
| Income Taxes Payable | 155 | 207 |
| Deferred Revenue | 3,579 | 3,287 |
| Accrued and other current liabilities | 3,099 | 2,103 |
| Total current liabilities | 12,125 | 10,386 |
| Long-term Debt | 1,686 | 1,953 |
| Deferred Income Tax Liabilities | 251 | 478 |
| Pension and other post employment benefits - noncurrent | 2,434 | 2,271 |
| Other noncurrent obligations | 1,963 | 1,707 |
| Total Noncurrent Liabilities | 6,334 | 6,409 |
| Common Stock, Shares, Issued | 672,163 | 685,595 |
| Common stock | 7 | 7 |
| Additional Paid in Capital | 27,001 | 27,196 |
| Retained earnings (accumulated deficit) | -67 | 55 |
| Accumulated other comprehensive income (loss) | -2,797 | -3,469 |
| Total stockholders' equity attributable to the company | 24,144 | 23,789 |
| Noncontrolling Interests | 242 | 241 |
| Total Equity | 24,386 | 24,030 |
| Total Liabilities and Equity | 42,845 | 40,825 |
| Cash and Cash Equivalents | 4,521 | 3,106 |
| Marketable Securities | 9 | 63 |
| Accounts and notes receivable - net | 6,371 | 5,676 |
| Inventories | 5,667 | 5,432 |
| Other current assets | 767 | 820 |
| Total current assets | 17,335 | 15,097 |
| Investments in nonconsolidated affiliates | 160 | 134 |
| Property, Plant and Equipment | 9,551 | 9,074 |
| Less: Accumulated Depreciation | 5,331 | 4,975 |
| Net Property, Plant and Equipment | 4,220 | 4,099 |
| Goodwill | 10,465 | 10,408 |
| Other intangible assets | 8,301 | 8,876 |
| Deferred Income Taxes | 320 | 401 |
| Other Assets | 2,044 | 1,810 |
| Total Assets | 42,845 | 40,825 |
| Short-term borrowings and finance lease obligations | 894 | 750 |
| Accounts Payable | 4,398 | 4,039 |
| Income Taxes Payable | 155 | 207 |
| Deferred Revenue | 3,579 | 3,287 |
| Accrued and other current liabilities | 3,223 | 2,096 |
| Total current liabilities | 12,249 | 10,379 |
| Long-term Debt | 1,686 | 1,953 |
| Deferred Income Tax Liabilities | 251 | 478 |
| Pension and other post employment benefits - noncurrent | 2,434 | 2,271 |
| Other noncurrent obligations | 1,963 | 1,707 |
| Total Noncurrent Liabilities | 6,334 | 6,409 |
| Common stock | 0 | 0 |
| Additional Paid in Capital | 24,610 | 24,464 |
| Retained earnings (accumulated deficit) | 2,207 | 2,930 |
| Accumulated other comprehensive income (loss) | -2,797 | -3,469 |
| Total stockholders' equity attributable to the company | 24,259 | 24,035 |
| Noncontrolling Interests | 3 | 2 |
| Total Equity | 24,262 | 24,037 |
| Total Liabilities and Equity | 42,845 | 40,825 |
| Due from Parent | 0 | -129 |
| Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 2024 | 169 | 169 |
| Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 2024 | 70 | 70 |
Cash flow statement USD ($) $ in Millions
| Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | — | 1,105 | — | 919 | — | 747 | |||
| (Income) Loss from Discontinued Operations, after income taxes | — | 99 | — | -56 | — | 194 | |||
| Depreciation and amortization | — | 1,203 | — | 1,227 | — | 1,211 | |||
| Provision for (benefit from) deferred income tax | — | -41 | — | -365 | — | -438 | |||
| Net periodic pension and OPEB (benefit) cost, net | — | 36 | — | 160 | — | 138 | |||
| Pension and OPEB contributions | — | -136 | — | -151 | — | -149 | |||
| Net (gain) loss on sales of property, businesses, consolidated companies and investments | — | -41 | — | -17 | — | -22 | |||
| Restructuring and Asset Related Charges - net | — | 146 | — | 288 | — | 336 | |||
| Other net loss | — | 545 | — | 383 | — | 578 | |||
| Accounts and Notes Receivable | — | -261 | — | -705 | — | 358 | |||
| Inventories | — | -35 | — | 1,110 | — | 57 | |||
| Accounts Payable | — | 231 | — | -115 | — | -663 | |||
| Deferred Revenue | — | 270 | — | -86 | — | -11 | |||
| Other Assets and Liabilities | — | 336 | — | -296 | — | -527 | |||
| Cash Provided by (Used for) Operating Activities - Continuing Operations | — | 3,457 | — | 2,296 | — | 1,809 | |||
| Cash Provided by (Used for) Operating Activities - Discontinued Operations | — | -51 | — | -151 | — | -40 | |||
| Cash provided by (used for) operating activities | — | 3,406 | — | 2,145 | — | 1,769 | |||
| Capital expenditures | — | -591 | — | -597 | — | -595 | |||
| Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested | — | 54 | — | 5 | — | 57 | |||
| Acquisitions of businesses - Net of Cash Acquired | — | 0 | — | 0 | — | -1,456 | |||
| Investments in and loans to nonconsolidated affiliates | — | -20 | — | -7 | — | -32 | |||
| Purchases of investments | — | 0 | — | -144 | — | -148 | |||
| Proceeds from Sale and Maturities of Investments | — | 135 | — | 130 | — | 147 | |||
| Payments for (Proceeds from) Hedge, Investing Activities | — | -83 | — | 63 | — | 42 | |||
| Other investing activities - net | — | -38 | — | -39 | — | -2 | |||
| Cash provided by (used for) investing activities | — | -543 | — | -589 | — | -1,987 | |||
| Net Change in borrowings (less than 90 days) | — | 0 | — | 53 | — | -6 | |||
| Proceeds from Debt | — | 1,730 | — | 3,072 | — | 3,429 | |||
| Payments on Debt | — | -1,871 | — | -2,885 | — | -2,309 | |||
| Repurchase of Common Stock | — | -1,071 | — | -1,009 | — | -756 | |||
| Proceeds from Exercise of Stock Options | — | 88 | — | 60 | — | 31 | |||
| Dividends Paid to stockholders | — | -475 | — | -458 | — | -439 | |||
| Other financing activities, net | — | -45 | — | -32 | — | -49 | |||
| Cash provided by (used for) financing activities | — | -1,644 | — | -1,199 | — | -99 | |||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | — | 84 | — | -93 | — | -143 | |||
| Increase (decrease) on cash, cash equivalents and restricted cash | — | 1,303 | — | 264 | — | -460 | |||
| Cash, cash equivalents and restricted cash equivalents at beginning of period | — | 3,422 | [1] | 3,158 | [1] | 3,618 | |||
| Cash, cash equivalents and restricted cash equivalents at end of period | [1] | 4,725 | — | 3,422 | — | 3,158 | |||
| Interest, net of amounts capitalized | — | 191 | — | 244 | — | 234 | |||
| Income Taxes | — | 750 | — | 707 | — | 535 | |||
| Net income (loss) | — | 1,105 | — | 949 | — | 732 | |||
| (Income) Loss from Discontinued Operations, after income taxes | — | 99 | — | -56 | — | 194 | |||
| Depreciation and amortization | — | 1,203 | — | 1,227 | — | 1,211 | |||
| Provision for (benefit from) deferred income tax | — | -41 | — | -365 | — | -438 | |||
| Net periodic pension and OPEB (benefit) cost, net | — | 36 | — | 160 | — | 138 | |||
| Pension and OPEB contributions | — | -136 | — | -151 | — | -149 | |||
| Net (gain) loss on sales of property, businesses, consolidated companies and investments | — | -41 | — | -17 | — | -22 | |||
| Restructuring and Asset Related Charges - net | — | 146 | — | 288 | — | 336 | |||
| Other net loss | — | 545 | — | 383 | — | 578 | |||
| Accounts and Notes Receivable | — | -261 | — | -705 | — | 358 | |||
| Inventories | — | -35 | — | 1,110 | — | 57 | |||
| Accounts Payable | — | 231 | — | -115 | — | -663 | |||
| Deferred Revenue | — | 270 | — | -86 | — | -11 | |||
| Other Assets and Liabilities | — | 336 | — | -284 | — | -553 | |||
| Cash Provided by (Used for) Operating Activities - Continuing Operations | — | 3,457 | — | 2,338 | — | 1,768 | |||
| Cash Provided by (Used for) Operating Activities - Discontinued Operations | — | -51 | — | -151 | — | -40 | |||
| Cash provided by (used for) operating activities | — | 3,406 | — | 2,187 | — | 1,728 | |||
| Capital expenditures | — | -591 | — | -597 | — | -595 | |||
| Net payment from (advances to) Parent on in-house banking arrangement | — | 0 | — | 361 | — | — | |||
| Net payment from (advances to) Parent on in-house banking arrangement | — | — | — | — | — | -20 | |||
| Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested | — | 54 | — | 5 | — | 57 | |||
| Acquisitions of businesses - Net of Cash Acquired | — | 0 | — | 0 | — | -1,456 | |||
| Investments in and loans to nonconsolidated affiliates | — | -20 | — | -7 | — | -32 | |||
| Purchases of investments | — | 0 | — | -144 | — | -148 | |||
| Proceeds from Sale and Maturities of Investments | — | 135 | — | 130 | — | 147 | |||
| Payments for (Proceeds from) Hedge, Investing Activities | — | -83 | — | 63 | — | 42 | |||
| Other investing activities - net | — | -38 | — | -39 | — | -2 | |||
| Cash provided by (used for) investing activities | — | -543 | — | -228 | — | -2,007 | |||
| Net Change in borrowings (less than 90 days) | — | 0 | — | 53 | — | -6 | |||
| Net payment from (advances to) Parent on in-house banking arrangement | — | 129 | — | — | — | — | |||
| Net payment from (advances to) Parent on in-house banking arrangement | — | — | — | -129 | — | 0 | |||
| Repayments of Related Party Debt | — | 0 | — | 0 | — | -1,129 | |||
| Proceeds from Debt | — | 1,730 | — | 3,072 | — | 3,429 | |||
| Payments on Debt | — | -1,871 | — | -2,885 | — | -2,309 | |||
| Proceeds from Exercise of Stock Options | — | 88 | — | 60 | — | 31 | |||
| Other financing activities, net | — | -38 | — | -23 | — | -54 | |||
| Cash provided by (used for) financing activities | — | -1,644 | — | -1,602 | — | -38 | |||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | — | 84 | — | -93 | — | -143 | |||
| Increase (decrease) on cash, cash equivalents and restricted cash | — | 1,303 | — | 264 | — | -460 | |||
| Cash, cash equivalents and restricted cash equivalents at beginning of period | — | 3,422 | — | 3,158 | — | 3,618 | |||
| Cash, cash equivalents and restricted cash equivalents at end of period | — | 4,725 | — | 3,422 | — | 3,158 | |||
| Interest, net of amounts capitalized | [2] | 191 | — | 244 | — | 234 | |||
| Income Taxes | — | 750 | — | 707 | — | 535 | |||
| Dividends Paid to stockholders | — | -1,682 | — | -1,750 | — | 0 | |||
| [1] See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. [2] Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements. | — | — | — | — | — | [1] | See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. | [2] | Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements. |
| [1] | See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. | ||||||||
| [2] | Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements. |
Note: Commitments and Contingent L'12
Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $49 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page F-43 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ").
Note: Commitments and Contingent Liab
NOTE 15 - COMMITMENTS AND CONTINGENT LIABILITIESGuaranteesIndemnificationsIn connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.Obligations for Supplier Finance ProgramsThe company enters into supplier finance programs with various finance providers in which the company agrees to pay these finance providers the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the finance provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At December 31, 2025 and 2024, the outstanding obligations under supplier finance programs was approximately $121 million and $88 million, respectively, and included within accounts payable in the Consolidated Balance Sheets.
Note: Long-Term Debt and Available Cr
Long-Term DebtDecember 31, 2025December 31, 2024(In millions)AmountWeighted Average RateAmountWeighted Average RatePromissory notes and debentures:Maturing in July 2025$— — %$500 1.70 %Maturing in May 2026600 4.50 %600 4.50 %Maturing in July 2030500 2.30 %500 2.30 %Maturing in May 2032500 5.125 %— — %Maturing in May 2033600 4.80 %600 4.80 %Other loans:Foreign currency loans, various rates and maturities182 12.70 %161 12.70 %Medium-term notes, varying maturities through 2041102 3.76 %104 4.
Note: Income Taxes
INCOME TAXES Domestic and foreign components of income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below: Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,(In millions)202520242023Income (loss) from continuing operations before income taxesDomestic$325 $324 $(414)Foreign1,363 951 1,507 Income (loss) from continuing operations before income taxes$1,688 $1,275 $1,093 Current tax expense (benefit)Federal$87 $285 $143 State and local26 45 40 Foreign412 447 407 Total current tax expense (benefit)$525 $777 $590 Deferred tax expense (benefit) Federal$(139)$(300)$(326)State and local(24)(28)(50)Foreign122 (37)(62)Total deferred tax expense (benefit)$(41)$(365)$(438)Provision for (benefit from) income taxes on continuing operations484 412 152 Net income (loss) from continuing operations after taxes$1,204 $863 $941 The table below provides the updated disclosure requirements of ASU 2023-09, which was adopted on a prospective basis for the year ended December 31, 2025. See Note 3 - Recent Accounting Guidance, to the Consolidated Financial Statements, for a description of the relevant disclosure requirements.The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table: Reconciliation to U.S. Statutory RateFor the Year Ended December 31,2025($ In millions)$%U.S. Federal statutory tax rate$354 21.0 %State and local income tax, net of federal (national) income tax effect 15 0.3 %Foreign tax effectsArgentinaStatutory tax rate differential(17)(1.0)%Withholding tax18 1.1 %Exchange gains/losses(31)(1.8)%Changes in valuation allowances73 4.3 %Other(3)(0.2)%BrazilWithholding tax37 2.2 %Changes in valuation allowances 2153 9.1 %Other(4)(0.2)%IndiaStatutory tax rate differential17 1.0 %Agriculture exemption(41)(2.4)%Withholding tax31 1.8 %Other1 0.1 %SwitzerlandStatutory tax rate differential(91)(5.4)%Cantonal income tax, net59 3.5 %Other(1)(0.1)%Other foreign jurisdictions49 2.9 %Effect of cross-border tax laws (net of related foreign tax credits)Global Intangible Low-Taxed Income (GILTI)24 1.4 %Other12 0.7 %Tax creditsU.S. research and development credit(47)(2.8)%Other foreign tax credits(52)(3.1)%Changes in valuation allowances 374 4.
Note: EIDP Income Taxes Rate Reconcil
Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, to the Consolidated Financial Statements, under the heading "Foreign Currency Risk.
Note: Stock-Based Compensation
STOCK-BASED COMPENSATIONPrior to the Corteva Separation, Corteva employees held equity awards, including stock options, share appreciation rights (“SARs”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”), which were denominated in DowDuPont common stock and, in some cases, in Dow Inc. common stock, and which had originally been issued under the DuPont Equity and Incentive Plan ("EIP"), the Dow Chemical Company 2012 Stock Incentive Plan or the Dow Chemical Company 1988 Award and Option Plan. As discussed in Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, on April 1, 2019 the company entered into an Employee Matters Agreement (the "EMA") with DuPont and Dow that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments were to occur. With some exceptions, the EMA provides for the equitable adjustment of existing equity incentive compensation awards denominated in the common stock of DowDuPont to reflect the occurrence of the Distributions.In connection with the Corteva Separation on June 1, 2019, outstanding DowDuPont-denominated stock options, SARs, RSU and PSU awards were converted into Corteva-denominated awards under the “Employer Method,” or into both DuPont-denominated awards and Corteva-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the Corteva Separation transactions. The conversions of equity awards did not have a material impact on the company’s Consolidated Financial Statements.On June 1, 2019 (“Adoption Date”), in connection with the Corteva Separation, the Omnibus Incentive Plan (the "OIP") became effective.
Note: Cybersecurity Risk Management a
CYBERSECURITYRisk Management and Strategy. The company’s risk management programs for cybersecurity are integrated into the company’s enterprise risk management and general compliance programs and processes. Our cybersecurity program utilizes a layered, defense-in-depth strategy to identify and mitigate cybersecurity threats. The company’s information security team is responsible for the day-to-day management of the company’s global information security program, which includes defining policies and procedures to safeguard our information systems and data, conducting vulnerability, threat and third-party information security assessments, information security event management (i.e., responding to ransomware and other cyber-attacks, business continuity and recovery), evaluating external cyber intelligence, supporting industry cybersecurity efforts and working with governmental agencies. The global information security team also develops training for personnel (e.g., employees and contractors) with access to Corteva’s system to support adherence to the company’s policies and procedures, along with increasing awareness of cyber-related risk. The personnel training includes, but is not limited to, mandatory onboarding training, phishing simulations with automated remediation training, table-top incident response exercises, and educational intranet posting and email campaigns.Our Enterprise Risk Management Committee, which includes the company’s Chief Information Officer (“CIO”) and Chief Information Security Officer (“CISO”), independently assesses and monitors the effectiveness of the company’s cybersecurity risk management programs and strategies. The company’s internal audit function also performs independent reviews and validation of the various programs, including policies and procedures as determined by their annual risk assessment. The company leverages the U.S. Department of Commerce’s National Institute of Standards and Technology (“NIST”) Cybersecurity Framework (“Framework”) as the foundation of its global information security program. The NIST Framework provides standards, guidelines, and practices for organizations to better manage and reduce cybersecurity risk and is designed to foster risk and cybersecurity management communications amongst both internal and external organizational stakeholders.
Note: DEI Document
Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2026 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy).
Long notes are shortened. The full text is in the filing.
Filings
Newest first, from SEC EDGAR
- Current report (8-K) ↗ Filed 13 Oct 2026
- Current report (8-K) ↗ Filed 7 Oct 2026
- Current report (8-K) ↗ Filed 7 Oct 2026
- Current report (8-K) ↗ Filed 5 Oct 2026
- Current report (8-K) ↗ Filed 1 Oct 2026
- Current report (8-K) ↗ Filed 1 Oct 2026
- Quarterly report (10-Q) ↗ Filed 31 Jul 2026
- Quarterly report (10-Q) ↗ Filed 6 May 2026
- Proxy statement (DEF 14A) ↗ Filed 19 Mar 2026
- Quarterly report (10-Q) ↗ Filed 5 Nov 2025
- Quarterly report (10-Q) ↗ Filed 7 Aug 2025
- Proxy statement (DEF 14A) ↗ Filed 21 Mar 2025
- Annual report (10-K) ↗ Filed 14 Feb 2025
- Annual report (10-K) ↗ Filed 8 Feb 2024
- Annual report (10-K) ↗ Filed 9 Feb 2023
- Annual report (10-K) ↗ Filed 10 Feb 2022
Sources and methodology
- Data on this tab
- SEC EDGAR and our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.